What are the best treatments for Coats Disease?

The primary goal of treating Coats Disease is to eliminate abnormal, leaking retinal blood vessels to preserve vision and prevent complications such as retinal detachment or glaucoma.

First-Line and Surgical Interventions

Treatment for Coats Disease is highly personalized based on the stage of the disease and the extent of fluid accumulation (exudation). Current clinical guidelines focus on ablative therapies to seal the telangiectatic (abnormal) vessels. Laser photocoagulation is the standard first-line treatment for mild to moderate cases. For patients with more extensive fluid, cryotherapy (freezing the abnormal vessels) may be utilized. In advanced cases where there is significant subretinal fluid or retinal detachment, surgical interventions such as vitrectomy or scleral buckling are necessary to stabilize the eye.

Medications and Emerging Therapies

While there is no systemic medication to cure Coats Disease, anti-VEGF (Vascular Endothelial Growth Factor) agents, such as bevacizumab (Avastin) or aflibercept (Eylea), are frequently used as an adjunct to laser or surgical therapy. These injections help reduce retinal edema and vascular leakage. Research is ongoing into the efficacy of these anti-VEGF agents as a primary monotherapy, though long-term data regarding their ability to replace traditional laser therapy is still evolving.

Multidisciplinary Care

Managing Coats Disease requires a dedicated, multidisciplinary team. A pediatric retina specialist or a vitreoretinal surgeon is essential for managing the ocular manifestations. Depending on the patient's age and visual status, the care team should also include an ophthalmologist, an ocular oncologist (to rule out retinoblastoma, which can mimic the condition), and low-vision specialists. Because the disease often affects children, pediatric psychologists are vital to support the patient and family through the stress of repeated eye exams and surgical procedures.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. Treatment plans for Coats Disease must be individualized by your healthcare team based on your specific clinical presentation; always consult with your physician regarding your diagnosis and care.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Coats Disease


• Orphanet: Coats disease (ORPHA:1879)


• American Academy of Ophthalmology (AAO): Coats Disease Treatment Guidelines